Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mistletoe therapy for advanced pancreatic cancer
ISRCTN70760582Phase 3Completed
- Sponsor
- American Association for Cancer Research
- Start
- Jan 2009
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, open-label trial of Iscador Qu Spezial in pancreatic adenocarcinoma (PDAC) (2 arms), sponsored by American Association for Cancer Research. Primary endpoint: Overall survival rate. Started Jan 2009; status: completed.
02
Drugs
Iscador Qu Spezial
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on ISRCTN70760582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN70760582.